11/21
10:00 am
ngne
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Neurogene Inc. (NGNE) and Encourages Investors to Learn More About the Investigation
Medium
Report
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Neurogene Inc. (NGNE) and Encourages Investors to Learn More About the Investigation
11/21
07:30 am
ngne
Neurogene Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Neurogene Inc. (NGNE)
Low
Report
Neurogene Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Neurogene Inc. (NGNE)
11/20
12:45 pm
ngne
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE
Medium
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE
11/20
10:00 am
ngne
Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Medium
Report
Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
11/20
09:31 am
ngne
Neurogene Inc. (NASDAQ: NGNE) had its price target lowered by analysts at BMO Capital Markets from $60.00 to $45.00. They now have an "outperform" rating on the stock.
Medium
Report
Neurogene Inc. (NASDAQ: NGNE) had its price target lowered by analysts at BMO Capital Markets from $60.00 to $45.00. They now have an "outperform" rating on the stock.
11/20
07:25 am
ngne
Neurogene Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Neurogene Inc. (NGNE)
High
Report
Neurogene Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Neurogene Inc. (NGNE)
11/19
11:41 am
ngne
Neurogene Inc. (NASDAQ: NGNE) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
Neurogene Inc. (NASDAQ: NGNE) had its "outperform" rating re-affirmed by analysts at William Blair.
11/19
10:00 am
ngne
Bronstein, Gewirtz & Grossman, LLC Is Investigating Neurogene Inc. (NGNE) And Encourages Investors to Connect
Medium
Report
Bronstein, Gewirtz & Grossman, LLC Is Investigating Neurogene Inc. (NGNE) And Encourages Investors to Connect
11/19
08:20 am
ngne
Neurogene Inc. (NASDAQ: NGNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
High
Report
Neurogene Inc. (NASDAQ: NGNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
11/19
07:25 am
ngne
NGNE ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Neurogene Inc. Shareholders Who Lost Money
High
Report
NGNE ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Neurogene Inc. Shareholders Who Lost Money
11/18
07:24 pm
ngne
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE
High
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE
11/18
05:25 pm
ngne
Neurogene Reports Third Quarter 2024 Financial Results and Highlights Recent Updates
High
Report
Neurogene Reports Third Quarter 2024 Financial Results and Highlights Recent Updates
11/18
10:00 am
ngne
Bronstein, Gewirtz & Grossman, LLC Is Investigating Neurogene Inc. (NGNE) And Encourages Stockholders to Connect
Medium
Report
Bronstein, Gewirtz & Grossman, LLC Is Investigating Neurogene Inc. (NGNE) And Encourages Stockholders to Connect
11/18
07:30 am
ngne
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Neurogene Inc. (NGNE)
High
Report
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Neurogene Inc. (NGNE)
11/18
06:45 am
ngne
Neurogene Provides Update on NGN-401 Gene Therapy Clinical Trial for Rett Syndrome
High
Report
Neurogene Provides Update on NGN-401 Gene Therapy Clinical Trial for Rett Syndrome
11/17
10:00 am
ngne
Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
High
Report
Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
11/15
10:15 am
ngne
Neurogene Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - NGNE
Medium
Report
Neurogene Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - NGNE
11/15
10:00 am
ngne
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Neurogene Inc. (NGNE) and Encourages Stockholders to Learn More About the Investigation
Medium
Report
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Neurogene Inc. (NGNE) and Encourages Stockholders to Learn More About the Investigation
11/14
10:30 am
ngne
ATTENTION Neurogene Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
Low
Report
ATTENTION Neurogene Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
11/14
10:00 am
ngne
Bronstein, Gewirtz & Grossman, LLC Encourages Neurogene Inc. (NGNE) Investors to Inquire about Securities Investigation
Medium
Report
Bronstein, Gewirtz & Grossman, LLC Encourages Neurogene Inc. (NGNE) Investors to Inquire about Securities Investigation
11/13
03:30 pm
ngne
Shareholders that Lost Money on Neurogene Inc. (NGNE) Should Contact Levi & Korsinsky About Securities Fraud Investigation - NGNE
Low
Report
Shareholders that Lost Money on Neurogene Inc. (NGNE) Should Contact Levi & Korsinsky About Securities Fraud Investigation - NGNE
11/13
11:30 am
ngne
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neurogene Inc. (NGNE) And Encourages Investors to Reach Out
Medium
Report
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neurogene Inc. (NGNE) And Encourages Investors to Reach Out
11/13
11:00 am
ngne
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE
11/12
02:31 pm
ngne
Neurogene Inc. (NASDAQ: NGNE) had its price target raised by analysts at Stifel Nicolaus from $44.00 to $60.00. They now have a "buy" rating on the stock.
Medium
Report
Neurogene Inc. (NASDAQ: NGNE) had its price target raised by analysts at Stifel Nicolaus from $44.00 to $60.00. They now have a "buy" rating on the stock.
11/12
12:36 pm
ngne
Neurogene Inc. (NASDAQ: NGNE) had its price target lowered by analysts at BMO Capital Markets from $65.00 to $60.00. They now have an "outperform" rating on the stock.
Medium
Report
Neurogene Inc. (NASDAQ: NGNE) had its price target lowered by analysts at BMO Capital Markets from $65.00 to $60.00. They now have an "outperform" rating on the stock.